Strategic Education (STRA) director reports 700-share sale at $81.69
Rhea-AI Filing Summary
Strategic Education, Inc. (STRA) director Thomas G. Waite III reported an open-market sale of 700 shares on 08/26/2025 at a price of $81.69 per share. Following the sale he beneficially owns 15,926 shares, held directly. The Form 4 was filed as a single reporting person submission and the filing was signed by an attorney-in-fact, Daniel W. Jackson, on 08/26/2025. No derivative transactions or other securities classes are reported on this form.
Positive
- None.
Negative
- None.
Insights
TL;DR: A routine director sale of 700 shares at $81.69, leaving 15,926 shares outstanding for the insider; no derivatives reported.
The transaction is a straightforward disposition by a director rather than company-level news. The sale size (700 shares) appears modest relative to the remaining beneficial holding (15,926 shares). There are no accompanying derivative exercises or changes to ownership form disclosed, and the Form 4 indicates a single reporting person. Based solely on this filing, there is no evidence of broader corporate action or material change to the company’s capital structure.
TL;DR: Director reporting a small open-market sale; filing was executed by an attorney-in-fact and contains no unusual disclosures.
The Form 4 documents an ordinary course sale by a director. The signature by an attorney-in-fact is properly indicated and dated. The filing does not show accelerated sales under a Rule 10b5-1 plan or any indirect holdings; ownership is reported as direct. From a governance and disclosure compliance perspective, the form provides the required information and contains no additional governance-related events.
FAQ
What insider transaction did STRA director Thomas G. Waite III report?
How many STRA shares does the reporting person own after the transaction?
Were any derivative securities or option transactions disclosed in this Form 4 for STRA?
Was the Form 4 filed by more than one reporting person or signed by an agent?
Does the Form 4 indicate the sale was made under a 10b5-1 plan?